Viewing nowCombinationOlmesartan Medoxomil Hydrochlorothiazide Plus Tablet
Olmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.

MFDS item code 201100911 · Approved 2011.02.24 · Insurance code 640902310
Treatment for controlling blood pressure in essential hypertension
This medication is used in patients with essential hypertension whose blood pressure control is insufficient with Olmesartan Medoxomil or Hydrochlorothiazide alone. It effectively lowers blood pressure and helps reduce the risk of cardiovascular complications.
This medication is to be taken once daily with or without food. Dosage should be adjusted every 2 to 4 weeks based on the patient's blood pressure response. In the elderly, treatment should start at the lowest dose, and dosage adjustments must take into account kidney function, heart function, comorbid conditions, and concomitant medications.
Safety and efficacy in children have not been established.
This medication may cause serious harm or death to the fetus or newborn if taken during the second and third trimesters of pregnancy, therefore it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to this drug or its components, specific kidney or liver diseases, or in women who are pregnant or breastfeeding. Patients with significantly low blood pressure, severely impaired kidney function, and certain electrolyte abnormalities should use this medication with caution, and their conditions should be closely monitored before and during treatment. As this medication lowers blood pressure, dizziness or symptoms of hypotension may occur when starting treatment, and appropriate actions should be taken if symptoms arise. It can affect kidney function; therefore, patients with impaired kidney function should have regular blood tests to check kidney status. Patients with severely impaired liver function or certain heart diseases also require caution, and electrolyte imbalances or dehydration should be managed. This medication may increase the risk of skin cancer; therefore, sun exposure should be minimized, and any skin abnormalities should be immediately consulted with a doctor. During treatment, symptoms such as dizziness, headache, indigestion, muscle pain, rash, and others may occur, and if there are severe edema or breathing difficulties, healthcare personnel should be informed immediately. This medication can interact with other drugs; therefore, especially if taking potassium supplements, diuretics, lithium, or anti-inflammatory drugs, it is essential to inform healthcare personnel and be cautious. Pregnant and breastfeeding women should pay special attention to taking this medication, and breastfeeding should be avoided or paused while taking this medication. In children and the elderly, the safety and efficacy of this medication have not been well established, or there may be impaired kidney function, so dosage adjustments and caution are necessary. In cases of overdose, symptoms such as hypotension, electrolyte imbalance, and dehydration may occur, and appropriate treatment should be received at a medical institution immediately. Regular blood tests and monitoring of electrolytes, kidney function, and liver function during medication use are important.
Urticaria, severe swelling (edema), angioedema, anaphylactic reaction, severe skin adverse reactions, urticaria, angioedema, facial swelling, liver abnormalities (jaundice), jaundice, acute renal failure, acute respiratory distress syndrome (ARDS), breathing difficulties, asthma attacks, severe hypotension, kidney function impairment, seizures, confusion, visual disturbances, paralysis, severe neurological symptoms, hyponatremia, frequent urination, severe edema, hyperkalemia, urinary difficulties
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1°C and 25°C. By storing it this way, the effectiveness and safety of the medication can be maintained for a long time.
Round film-coated tablet with yellowish color
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
Olmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Prescription medication · Combination
Kookje Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.